Tirzepatide is a synthetic dual incretin peptide designed to mimic GLP-1 and GIP activity in metabolic research models. It has been studied for its effects on...
Tirzepatide is a synthetic dual incretin peptide designed to mimic GLP-1 and GIP activity in metabolic research models. It has been studied for its effects on glucose regulation, appetite control, and energy balance, with observed impacts on body weight and metabolic markers in preclinical and clinical investigations.
Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
Tirzepatide is a synthetic, long-chain peptide designed to mimic naturally occurring incretin hormones. It is classified as a dual-acting GLP-1/GIP peptide, with a modified amino acid sequence that supports stability and consistency in research. This compound has a molecular weight of approximately 4813.48 g/mol and is typically supplied as a high-purity lyophilized powder in a 5mg vial.
Tirzepatide is used in research to explore its role in metabolic signaling and glucose-related processes. It is commonly employed in controlled laboratory environments to study how peptide-based compounds interact with metabolic systems and cellular responses.
For laboratory research use only.
Tirzepatide is being studied for its role in metabolic regulation and endocrine processes. Specifically, research focuses on its potential to influence glucose signaling, insulin-related pathways, and energy balance within controlled models.
Current studies also explore how this peptide interacts with appetite-related signaling and broader metabolic systems. Researchers aim to understand how dual-acting peptides can affect coordinated biological responses across multiple pathways.
Tirzepatide research has been conducted in in vitro and preclinical models, where varying concentrations are applied according to the experimental design. Findings from these studies primarily focus on metabolic signaling patterns and glucose-related processes. These observations remain limited to research settings and are not intended as clinical conclusions.
Store Tirzepatide (5mg) at –20°C in a controlled laboratory setting, protected from light, heat, and moisture to maintain its structural integrity.
Once reconstituted, the solution should be refrigerated and handled according to appropriate protocols. To maintain consistency across experiments, avoid repeated freeze-thaw cycles.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals